Get notified when TTRX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsTurn Therapeutics files routine 8-K with undisclosed press release attachment
Filed May 27, 2026 · Period ending May 27, 2026 · ~1 min read
Key Changes
-
medium
Company issued press release on May 27, 2026, furnished under Regulation FD as Exhibit 99.1. The 8-K filing body does not disclose the content of the press release.
Item 7.01 verify on EDGAR → -
low
This is a procedural filing with no material business events disclosed in the 8-K text itself. The substance of any announcement would be in the attached press release.
8-K: Reg FD Disclosure verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.
Partner
Trade TTRX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · May 29, 2026 · How we verify